PubRank

I R Marino

Author PubWeight™ 82.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Baboon-to-human liver transplantation. Lancet 1993 4.01
2 Weaning of immunosuppression in liver transplant recipients. Transplantation 1997 1.57
3 The biological basis of and strategies for clinical xenotransplantation. Immunol Rev 1994 1.56
4 Hemolytic uremic syndrome in solid-organ transplant recipients. Transpl Int 1996 1.45
5 The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg 1998 1.42
6 The hepatic artery in liver transplantation and surgery: vascular anomalies in 701 cases. Clin Transplant 2001 1.40
7 Sociodemographic differences in early access to liver transplantation services. Am J Transplant 2009 1.30
8 Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis 1997 1.28
9 Development and experience with an integrated system for transplantation telepathology. Hum Pathol 2001 1.23
10 Hepatic Retransplantation--an analysis of risk factors associated with outcome. Transplantation 1996 1.22
11 Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted? Transplantation 1994 1.18
12 Temporary end to side portacaval shunt in orthotopic hepatic transplantation in humans. Surg Gynecol Obstet 1993 1.18
13 Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol 1995 1.15
14 Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis. Clin Infect Dis 1999 1.15
15 A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res 1996 1.13
16 Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation 2000 1.11
17 Methicillin-resistant Staphylococcus aureus: the other emerging resistant gram-positive coccus among liver transplant recipients. Clin Infect Dis 2000 1.10
18 Liver transplantation for metabolic disease of the liver. Gastroenterol Clin North Am 1988 1.04
19 Quality of life, functional status, and depression in male liver transplant recipients with recurrent viral hepatitis C. Transplantation 1999 1.04
20 Predicting outcomes after liver transplantation. A connectionist approach. Ann Surg 1994 1.02
21 Vulnerability to psychologic distress and depression in patients with end-stage liver disease due to hepatitis C virus. Clin Transplant 1997 1.01
22 Prospects of clinical xenotransplantation. Transplant Proc 1994 0.98
23 Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation. Transplantation 1989 0.98
24 Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial. Transplantation 1998 0.97
25 Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. Ann Surg 1996 0.95
26 Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transpl 2000 0.94
27 Staphylococcus aureus nasal colonization in patients with cirrhosis: prospective assessment of association with infection. Infect Control Hosp Epidemiol 1998 0.94
28 Cytomegalovirus antigenemia directed pre-emptive prophylaxis with oral versus I.V. ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, controlled trial. Transplantation 2000 0.94
29 Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients. Transplant Proc 1991 0.94
30 Depression in patients with cirrhosis. Impact on outcome. Dig Dis Sci 1997 0.93
31 Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. Int Surg 1989 0.92
32 Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation 1996 0.92
33 Outcome of patients with cirrhosis requiring intensive care unit support: prospective assessment of predictors of mortality. J Gastroenterol 1998 0.92
34 Staphylococcus aureus nasal colonization and association with infections in liver transplant recipients. Transplantation 1998 0.92
35 Fever in liver transplant recipients: changing spectrum of etiologic agents. Clin Infect Dis 1998 0.92
36 Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen. Transpl Int 1998 0.91
37 Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns. Liver Transpl 2001 0.89
38 Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. Clin Transplant 1997 0.89
39 Predictors and outcome of early- versus late-onset major bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression. Eur J Clin Microbiol Infect Dis 1997 0.87
40 Late-onset renal failure after liver transplantation: role of posttransplant alcohol use. Transplantation 2000 0.87
41 Toxoplasma gondii pneumonitis in a liver transplant recipient: implications for diagnosis. Liver Transpl Surg 1996 0.87
42 Quality of life in long-term survivors after liver transplantation: impact of recurrent viral hepatitis C virus hepatitis. Clin Transplant 2000 0.86
43 Intraoperative hypothermia is an independent risk factor for early cytomegalovirus infection in liver transplant recipients. Transplantation 1999 0.86
44 Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation 2001 0.86
45 Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation 1997 0.86
46 Variant B human herpesvirus-6 associated febrile dermatosis with thrombocytopenia and encephalopathy in a liver transplant recipient. Transplantation 1995 0.85
47 Psychological characteristics of candidates for liver transplantation: differences according to history of substance abuse and UNOS listing. United Network for Organ Sharing. J Clin Psychol 1999 0.84
48 Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity. Transplantation 1997 0.84
49 Malignant fibrous histiocytoma of the gallbladder: case report and review of the literature. Am Surg 2001 0.84
50 Orthotopic liver transplantation in pigs. An evaluation of different methods of avoiding the revascularization syndrome. Transplantation 1985 0.84
51 Mycobacterium mucogenicum bacteremia in a patient with cirrhosis. J Clin Gastroenterol 1998 0.83
52 Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil. Transplantation 1998 0.83
53 Recent advances in hepatic transplantation at the University of Pittsburgh. Clin Transpl 1993 0.83
54 Pulmonary infiltrates in liver transplant recipients in the intensive care unit. Transplantation 1999 0.83
55 The presence of B-cell nodules does not necessarily portend a less favorable outcome to therapy in patients with acute cellular rejection of a renal allograft. Transplant Proc 2006 0.83
56 Bloodstream infections in liver transplant recipients receiving tacrolimus. Clin Transplant 1997 0.82
57 Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Clin Infect Dis 1997 0.82
58 Causes of leukocytosis in liver transplant recipients: relevance in clinical practice. Transplantation 1998 0.82
59 Encephalopathy associated with human herpesvirus 6 in a liver transplant recipient. Liver Transpl Surg 1999 0.81
60 Human liver xenotransplantation. Xeno 1993 0.81
61 Successful reconstruction of late portal vein stenosis after hepatic transplantation. Arch Surg 1989 0.80
62 Interferon-alpha therapy for hepatitis C virus recurrence after liver transplantation: long-term response with maintenance therapy. Clin Transplant 1996 0.80
63 Pulmonary infections in liver transplant recipients receiving tacrolimus. Changing pattern of microbial etiologies. Transplantation 1996 0.80
64 Basiliximab induction in adult liver transplant recipients with 93% rejection-free patient and graft survival at 24 months. Transplant Proc 2006 0.80
65 Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. Transplantation 1998 0.79
66 Psychological characteristics of candidates for liver transplantation. Clin Transplant 1998 0.79
67 Correlation between peri-operative serum lactate levels and outcome in pancreatic resection for pancreatic cancer, preliminary report. J Exp Clin Cancer Res 2002 0.78
68 Pulmonary nodules in liver transplant recipients. Medicine (Baltimore) 1998 0.78
69 Late onset cytomegalovirus disease in liver transplant recipients: de novo reactivation in recurrent hepatitis C virus hepatitis. Transpl Int 1998 0.78
70 Acute adrenal insufficiency in critically ill liver transplant recipients. Implications for diagnosis. Transplantation 1995 0.78
71 Parvovirus B19 infection in a liver transplant recipient: case report and review in organ transplant recipients. Clin Transplant 1996 0.78
72 Kidney transplantation in Pittsburgh: experience and innovations. Clin Transpl 1987 0.77
73 Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation. Transplantation 1997 0.77
74 Hepatic encephalopathy: lack of changes of gamma-aminobutyric acid content in plasma and cerebrospinal fluid. Hepatology 1987 0.76
75 Heteroagglutinins and their significance in baboon hepatic xenotransplantation. Transplantation 1995 0.76
76 Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients. Transplantation 1997 0.76
77 Hemodynamic effects of inhaled nitric oxide in four patients with severe liver disease and pulmonary hypertension. Liver Transpl Surg 1997 0.76
78 Multicultural issues in organ transplantation: the influence of patients' cultural perspectives on compliance with treatment. Clin Transplant 1997 0.76
79 Quality of life and functional status of liver transplant recipients with recurrent viral hepatitis C. Transplant Proc 1999 0.76
80 Building clinical classifiers using incomplete observations--a neural network ensemble for hepatoma detection in patients with cirrhosis. Methods Inf Med 1995 0.76
81 Spontaneous gram-negative cellulitis in a liver transplant recipient. Infection 2001 0.75
82 Effect of donor age liver allograft function. Transplantation 1996 0.75
83 Effect of HLA match in liver transplantation. Transplantation 1995 0.75
84 Changes in biliary (high-molecular-mass) and liver isoforms of alkaline phosphatase after baboon-to-human liver transplantation. Clin Chem 1994 0.75
85 Long-term survival of heart and liver xenografts with splenectomy and FK 506. Transplant Proc 1993 0.75
86 Liver transplantation for hereditary tyrosinemia in the presence of hepatocellular carcinoma. Transplant Proc 1989 0.75
87 Complement activation correlates with graft damage in baboon-to-human liver xenotransplantation. Transplant Proc 1994 0.75
88 Adult respiratory distress syndrome secondary to end-stage liver disease-successful outcome following liver transplantation. Transplantation 1993 0.75
89 Efficacy of Aspergillus galactomannan-directed preemptive therapy for the prevention of invasive aspergillosis in organ transplant recipients. Transpl Infect Dis 2002 0.75
90 Changes in serum electrolytes during treatment of patients in liver failure with molecular adsorbent recirculating system. Int J Artif Organs 2003 0.75
91 Continuous intra-venous (CIV) infusion of desferrioxamine (DF) in a hemodialysed patient with transfusion siderosis. Int J Artif Organs 1981 0.75
92 Rapidly fatal bacteremia due to Staphylococcus aureus producing both enterotoxins A and B in a liver transplant recipient. Clin Infect Dis 1997 0.75
93 Liver cold storage using UW solution: clinical results in 23 consecutive transplants. Transplant Proc 1990 0.75
94 [Emergency vascular access with a double-lumen subclavian catheter]. Minerva Chir 1988 0.75
95 Optimism and coping styles: A comparison of candidates for liver transplantation with candidates for lung transplantation. Psychother Psychosom 1999 0.75
96 [Primary lymphomas of the stomach]. Ann Ital Chir 1981 0.75
97 Polyacrylonitrile hemofiltration for the adsorption myoglobin in tardy revascularization syndrome: in vitro assessment. Int J Artif Organs 1983 0.75
98 [Deferoxamine B treatment of hemosiderosis in the anephric patient undergoing hemodialysis]. Chir Patol Sper 1981 0.75
99 [Chylothorax as a rare late complication of post-traumatic diaphragmatic hernia]. Ann Ital Chir 1981 0.75
100 Sutureless cholecystojejunostomy in pigs using an absorbable intraluminal stent and fibrin glue. J Invest Surg 1996 0.75
101 Fever in liver transplant recipients in the intensive care unit. Clin Transplant 1999 0.75
102 Therapy for advanced thyroid cancer: treatment of a high risk case. Ital J Surg Sci 1987 0.75
103 Orthotopic liver transplantation in U.S. veterans under primary tacrolimus immunosupression. Surg Technol Int 1996 0.75
104 Intestinal transplantation: current status and latest developments. Surg Technol Int 1999 0.75
105 c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts. Transplant Proc 2006 0.75
106 In situ versus bench resection of liver allografts before orthotopic liver transplantation. Transplant Proc 1989 0.75
107 [Selective ligation of the hepatic artery in treatment of post-traumatic hemobilia. Case report]. Minerva Chir 1979 0.75
108 Lactate levels in open interstitial thermal ablation for liver tumors. J Exp Clin Cancer Res 2002 0.75
109 [Two-stage preparation of the vascular access for hemodialysis in children: technical note]. Ann Ital Chir 1981 0.75
110 [Dumbbell neurogenic tumors in children]. Pediatr Med Chir 1990 0.75